{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:49:15Z","timestamp":1790603355237,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.canlet.2025.217624","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T16:17:05Z","timestamp":1741623425000},"page":"217624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["UBE2C mediates follicular thyroid carcinoma invasion and metastasis via K29-Specific vimentin ubiquitination"],"prefix":"10.1016","volume":"617","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikuo","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muye","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8515-1179","authenticated-orcid":false,"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2025.217624_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.canlet.2025.217624_bib3","article-title":"Long\u2010term oncological outcomes of follicular thyroid cancer in adolescents and young adults: a nationwide population\u2010based study","author":"Van De Berg","year":"2024","journal-title":"World J. Surg."},{"key":"10.1016\/j.canlet.2025.217624_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.canlet.2025.217624_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrm2780","article-title":"Building ubiquitin chains: E2 enzymes at work","volume":"10","author":"Ye","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2025.217624_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162434","article-title":"The UBE2C\/CDH1\/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells","volume":"133","author":"Zhang","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.canlet.2025.217624_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s13277-011-0291-1","article-title":"Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker","volume":"33","author":"Hao","year":"2012","journal-title":"Tumor Biol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217624_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1158\/1541-7786.MCR-19-0561","article-title":"UBE2C is upregulated by estrogen and promotes epithelial-mesenchymal transition via p53 in endometrial cancer","volume":"18","author":"Liu","year":"2020","journal-title":"Mol Cancer Res MCR"},{"issue":"3","key":"10.1016\/j.canlet.2025.217624_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10549-022-06531-5","article-title":"Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer","volume":"192","author":"Kariri","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.canlet.2025.217624_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217624_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217153","article-title":"TGF-\u03b2-induced lncRNA TBUR1 promotes EMT and metastasis in lung adenocarcinoma via hnRNPC-mediated GRB2 mRNA stabilization","volume":"600","author":"Huang","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2025.217624_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib13","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1038\/s41467-019-13852-5","article-title":"RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers","volume":"10","author":"Pang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217624_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217179","article-title":"Enhanced desmosome assembly driven by acquired high-level desmoglein-2 promotes phenotypic plasticity and endocrine resistance in ER+ breast cancer","volume":"600","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.canlet.2025.217624_bib15","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/cancers12010184","article-title":"Vimentin intermediate filaments as potential target for cancer treatment","volume":"12","author":"Strouhalova","year":"2020","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.canlet.2025.217624_bib17","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-14-2842","article-title":"Vimentin-ERK signaling uncouples slug gene regulatory function","volume":"75","author":"Virtakoivu","year":"2015","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.canlet.2025.217624_bib18","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/ijms20092228","article-title":"A comprehensive bioinformatics analysis of UBE2C in cancers","volume":"20","author":"Dastsooz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41420-022-00935-4","article-title":"Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma","volume":"8","author":"Xiang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13578-021-00555-y","article-title":"DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT\/mTOR signaling and UBE2C-mediated P53 ubiquitination","volume":"11","author":"Zhu","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2025.217624_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/15384101.2017.1356507","article-title":"Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death","author":"Guo","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2025.217624_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656364","article-title":"Aspects of the tumor microenvironment involved in immune resistance and drug resistance","volume":"12","author":"Khalaf","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2025.217624_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbrc.2019.12.058","article-title":"Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1","volume":"523","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.canlet.2025.217624_bib24","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1158\/0008-5472.CAN-10-4576","article-title":"CCI-779 inhibits cell-cycle G2\u2013M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability","volume":"71","author":"Wang","year":"2011","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2025.217624_bib25","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.7150\/ijbs.84067","article-title":"FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C\/mTOR signaling pathway","volume":"19","author":"Lv","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"7518","key":"10.1016\/j.canlet.2025.217624_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature13543","article-title":"Molecular architecture and mechanism of the anaphase-promoting complex","volume":"513","author":"Chang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.217624_bib27","article-title":"UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb","volume":"13","author":"Guo","year":"2023","journal-title":"Front. Oncol."},{"issue":"40","key":"10.1016\/j.canlet.2025.217624_bib28","doi-asserted-by":"crossref","first-page":"65876","DOI":"10.18632\/oncotarget.11674","article-title":"UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines","volume":"7","author":"Palumbo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217624_bib29","article-title":"Lactate regulates cell cycle by remodelling the anaphase promoting complex","author":"Liu","year":"2023","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.canlet.2025.217624_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115792","article-title":"Role of UBE2C in brain cancer invasion and dissemination","volume":"24","author":"Domentean","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.canlet.2025.217624_bib31","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.ejca.2007.09.003","article-title":"UbcH10 is overexpressed in malignant breast carcinomas","volume":"43","author":"Berlingieri","year":"2007","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"12","key":"10.1016\/j.canlet.2025.217624_bib32","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/emboj.2011.154","article-title":"Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth","volume":"30","author":"Chen","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.canlet.2025.217624_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40364-024-00571-3","article-title":"LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin","volume":"12","author":"Feng","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2025.217624_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106636","article-title":"PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation","volume":"187","author":"Li","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2025.217624_bib35","unstructured":"Knudsen N, Ulow IB, J\u00f8rgensen T, Perrild H, Ovesen L, Laurberg P. Serum Tg\u2014A Sensitive Marker of Thyroid Abnormalities and Iodine Deficiency in Epidemiological Studies.."},{"issue":"12","key":"10.1016\/j.canlet.2025.217624_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1089\/thy.2009.1609","article-title":"Lessons from mouse models of thyroid cancer","volume":"19","author":"Kim","year":"2009","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"7_suppl","key":"10.1016\/j.canlet.2025.217624_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.7_suppl.29","article-title":"Targeted combinatorial therapy of androgen receptor in androgen-independent prostate cancer cells","volume":"29","author":"Gomez-Pinillos","year":"2011","journal-title":"J. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525001880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525001880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T01:35:05Z","timestamp":1742693705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525001880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"alternative-id":["S0304383525001880"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217624","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UBE2C mediates follicular thyroid carcinoma invasion and metastasis via K29-Specific vimentin ubiquitination","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217624"}}